Document ID: chunk:federal_register_of_legislation:F2025L00049:schedule:4:p1
Version: federal_register_of_legislation:F2025L00049
Segment Type: schedule
Provision Reference: sch 4 (pt 1/22)
Character Range: 180751–184386

Schedule 4—Prescription only medicines and prescription animal remedies

Note 1: See sections 16, 28, 31 and 49, subsections 54(2) and 57(1) and section 60.
Note 2: Substances marked # are listed in Appendix D.
ABACAVIR.
ABALOPARATIDE.
ABATACEPT.
ABIRATERONE ACETATE.
ABCIXIMAB.
ABEMACICLIB.
ABROCITINIB.
ACALABRUTINIB.
ACAMPROSATE CALCIUM.
ACARBOSE.
ACEBUTOLOL.
ACEPROMAZINE.
ACETANILIDE and alkyl acetanilides (excluding when present as an excipient) for human therapeutic use.
ACETARSOL.
ACETAZOLAMIDE.
ACETOHEXAMIDE.
ACETYL ISOVALERYLTYLOSIN.
ACETYLCARBROMAL.
ACETYLCHOLINE.
ACETYLCYSTEINE except:
 (a) when included in Schedule 2; or
 (b) in preparations for oral use when labelled with a recommended daily dose of 1 g or less of acetylcysteine.
ACETYLDIGITOXIN.
ACETYLMETHYLDIMETHYLOXIMIDOPHENYLHYDRAZINE.
ACETYLSTROPHANTHIDIN.
ACICLOVIR except in preparations containing 5% or less of aciclovir for the treatment of herpes labialis in packs containing 10 g or less.
ACIPIMOX.
# ACITRETIN.
ACLIDINIUM BROMIDE.
ACOKANTHERA OUABAIO.
ACOKANTHERA SCHIMPERI.
ACONITUM spp. except:
 (a) when included in Schedule 2; or
 (b) in preparations for oral use in adults in packs containing 0.02 mg or less of total alkaloids; or
 (c) in preparations for dermal use in adults containing 0.02% or less of total alkaloids in packs containing 0.02 mg or less of total alkaloids.
ACRIVASTINE.
ADALIMUMAB.
ADAPALENE except when included in Schedule 3.
ADEFOVIR.
ADENOSINE for human therapeutic use in preparations for injection.
ADIPHENINE.
ADONIS VERNALIS.
ADRAFINIL.
ADRENALINE in:
 (a) topical preparations for the treatment of wounds in humans; or
 (b) all other preparations containing adrenaline except when included in or expressly excluded from Schedule 3.
ADRENOCORTICAL HORMONES except when separately specified in these Schedules.
AFAMELANOTIDE.
AFATINIB DIMALEATE.
AFLIBERCEPT.
AGALSIDASE.
AGLEPRISTONE.
AGOMELATINE.
ALANYLGLUTAMINE.
ALATROFLOXACIN MESILATE.
ALBENDAZOLE except:
 (a) when included in Schedule 5 or 6; or
 (b) in intraruminal implants each containing 3.85 g or less of albendazole for the treatment of animals.
ALCLOFENAC.
ALCLOMETASONE except when included in Schedule 3.
ALCURONIUM.
ALDESLEUKIN.
ALDOSTERONE.
ALECTINIB.
# ALEFACEPT.
ALEMTUZUMAB.
ALENDRONIC ACID.
ALFACALCIDOL.
ALFUZOSIN.
ALGLUCERASE.
ALGLUCOSIDASE.
ALIMEMAZINE except when included in Schedule 2 or 3.
ALIROCUMAB.
ALISKIREN.
ALKYL NITRITES except when separately specified in these Schedules.
ALLERGENS for therapeutic use.
ALLOPURINOL.
ALLYLESTRENOL.
ALOGLIPTIN.
ALOSETRON.
ALPELISIB.
ALPHA1‑PROTEINASE INHIBITOR (HUMAN).
ALPHADOLONE.
ALPHAXALONE.
ALPRENOLOL.
ALPROSTADIL.
ALSEROXYLON.
ALTEPLASE.
ALTRENOGEST.
ALTRETAMINE (hexamethylmelamine).
AMANTADINE.
AMBENONIUM CHLORIDE.
# AMBRISENTAN.
AMBUCETAMIDE.
AMBUTONIUM BROMIDE.
AMCINONIDE.
AMIFAMPRIDINE.
AMIFOSTINE.
AMIKACIN.
AMILORIDE.
AMINOCAPROIC ACID.
AMINOGLUTETHIMIDE.
5‑AMINOLEVULINIC ACID.
AMINOMETRADINE.
AMINOPHENAZONE (amidopyrine) and derivatives for the treatment of animals.
AMINOPHYLLINE except when included in Schedule 3.
AMINOPTERIN.
4‑AMINOPYRIDINE for therapeutic use.
AMINOREX.
AMINOSALICYLIC ACID.
AMIODARONE.
AMIPHENAZOLE.
AMISOMETRADINE.
AMISULPRIDE.
AMITRIPTYLINE.
AMLODIPINE.
AMMI VISNAGA.
AMMONIUM BROMIDE for therapeutic use.
AMOBARBITAL when packed and labelled for injection.
AMODIAQUINE.
AMOROLFINE except:
 (a) when included in Schedule 2; or
 (b) in preparations for the treatment of tinea pedis.
AMOXAPINE.
AMOXICILLIN.
AMPHOMYCIN.
AMPHOTERICIN B.
AMPICILLIN.
AMPRENAVIR.
AMRINONE.
AMSACRINE.
AMYL NITRITE except when included in Schedule 3.
AMYLOCAINE.
# ANABOLIC